Ranked by reported Q4 2025 13F market value
Share of total reported institutional value in ZJYL held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 118K | $26K | β | 1.505% | 0.00% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 107K | $23K | 0.0% | 1.361% | 0.00% |
| 3 | JANE STREET GROUP, LLC | 51K | $11K | β | 0.651% | 0.00% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 40K | $9K | β | 0.511% | 0.00% |
| 5 | ADVISOR GROUP HOLDINGS, INC. | 32K | $7K | +39.1% | 0.409% | 0.00% |
| 6 | XTX Topco Ltd | 29K | $6K | +61.1% | 0.366% | 0.00% |
| 7 | TWO SIGMA SECURITIES, LLC | 22K | $5K | β | 0.281% | 0.00% |
| 8 | UBS Group AG | 4K | $987 | -89.2% | 0.057% | 0.00% |
| 9 | Bell Investment Advisors, Inc | 152 | $34 | 0.0% | 0.002% | 0.00% |
| 10 | MORGAN STANLEY | 100 | $22 | -50.0% | 0.001% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in ZJYL β a direct measure of their conviction.
Filings activity in ZJYL during Q4 2025, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q4 2025 | 10 | +11% | 0.47% | 0.17 pp | $0M | 27% |
| Q3 2025 | 9 | 36% | 0.64% | 1.64 pp | $0M | 72% |
| Q2 2025 | 14 | 22% | 2.28% | 1.66 pp | $0M | 42% |
| Q1 2025 | 18 | +64% | 3.94% | 3.98 pp | $1M | 50% |
| Q4 2024 | 11 | 15% | 7.92% | 17.37 pp | $1M | 69% |
| Q3 2024 | 13 | +0.0% | 25.29% | +8.54 pp | $5M | +51% |
| Q2 2024 | 13 | 32% | 16.75% | +1.21 pp | $3M | +7.8% |
| Q1 2024 | 19 | β | 15.54% | β | $3M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ZJYL stock.
Based on Q4 2025 13F filings, institutional ownership of Jin Medical International Ltd. stands at 0.5%, held across 10 reporting institutions.
CITADEL ADVISORS LLC is the largest reported institutional holder of ZJYL, with approximately 117,794 shares worth $0.00B as of Q4 2025.
Yes β 4 widely-followed marquee investors appear among the top 25 institutional holders of ZJYL, including CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA SECURITIES, LLC.
Our composite Smart Money Score for ZJYL is 63 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
4 institutions opened new positions in ZJYL during Q4 2025, while 3 fully exited. 0 added to existing positions and 6 trimmed.
ZJYL institutional ownership fell by 0.17 percentage points quarter-over-quarter, with a net change of +1 holders.
The top 10 institutions account for 100.0% of all reported 13F value in ZJYL, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Jin Medical International Ltd. (ZJYL) Institutional Ownership